Positive outcomes in treating SCCs with PD‐1 inhibitors have been illustrated, probably due to the high expression of PD‐L1 in ESCC, CSCC, and HNSCCs.110, 111, 116, 117. The gene discussed is CD274; the disease is esophageal squamous cell carcinoma.